TrovaGene's PLK1 Inhibitor PCM-075 Demonstrates Synergy With A HDAC Inhibitor In Non-Hodgkin Lymphoma Cell Lines Post author:Sam Post published:August 20, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Pfizer Wins Expanded FDA Nod for Cancer Drug Sutent November 16, 2017 Ablynx Banks $200M IPO in Nasdaq Debut October 24, 2017 PTC Therapeutics CEO to Fight for DMD Therapy, Pushes Forward with SMA Treatment January 10, 2018